SOUTH AFRICA

Home / Products / Cats / Felocell 3® and 4® (CVR)

Felocell 3® and 4® (CVR)

Reg. no.G 3131 (Act 36/1947)

Reg. no. G 2913 (Act 36/1947)

Reg. no.G 3131 (Act 36/1947)

Reg. no. G 2913 (Act 36/1947)

Clindamycin is an inhibitor of protein synthesis in the bacterial cell. It binds to the 5OS subunit of the ribosome.

Expand All
  • Active Ingredients:
    • Felocell 3contains attenuated strains of feline herpesvirus type 1, calicivirus, and panleukopenia virus (Johnson Snow Leopard strain), propagated on established cell lines, and lyophilized to preserve stability.
    • Felocell 4contains attenuated strains of feline herpesvirus type 1, calicivirus, panleukopenia virus (Johnson Snow Leopard strain), and Chlamydophila felis propagated on established cell lines, and lyophilized to preserve stability.
  • Indications:
    • Felocell 3 (CVR) is intended for the vaccination of healthy cats and kittens as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), feline panleukopenia (FPL) caused by feline panleukopenia virus.
    • Felocell 4 (CVR-C) is intended for the vaccination of healthy cats and kittens as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), feline panleukopenia (FPL) caused by feline panleukopenia virus and feline chlamydiosis caused by Chlamydophila felis.
  • Warnings:
    • Keep out of reach of children, uninformed persons and animals.
    • Vaccination of pregnant queens should be avoided.
    • Postvaccination reactions attributable to the vaccine may include lethargy, anorexia, ocular discharge and fever.
    • If anaphylaxis or hypersensitivity occurs following use, administer adrenaline or equivalent. Without such treatment, serious reactions may result in death.
    • This vaccine has been shown to be efficacious but some cats may be unable to develop or maintain an adequate immune response following vaccination if they are, for example, incubating any infectious disease, are malnourished or parasitized, or are stressed due to transport or adverse environmental conditions, or otherwise immunocompromised, or the vaccine is not administered according to label directions.
  • Precautions:
    • Prolonged exposure to higher temperatures may adversely affect potency.
    • Use entire contents when first opened.
    • Sterilised syringes and needles should be used to administer this vaccine. Do not sterilise with chemicals because traces of disinfectant may inactivate the vaccine.
    • Admixing of the vaccine with any other may render it ineffective.
    • Burn containers and all unused contents.

    Dosage and Directions For Use:

    • Use only as directed. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided.

    General Directions:

    • Vaccination of healthy cats is recommended. Shake well. Aseptically administer 1 ml subcutaneously or intramuscularly.

    Primary vaccination:

    • Felocell 3: Healthy cats 9 weeks of age or older should receive 2 doses, each administered 3 - 4 weeks apart.
    • Felocell 4: Healthy cats 12 weeks of age or older should receive 2 doses, each administered 3 - 4 weeks apart.
      Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
      Revaccination:       Annual revaccination with a single dose is recommended.
  • Storage:
    • Store between 2 °C and 7 °C. Do not freeze.
  • Pack Sizes:
    • Felocell 3: 25 x 1 dose vials freeze dried vaccine and 25 vials sterile diluent packed in a clear, plastic, flip top container.
    • Felocell 4: 25 x 1 dose vials with 25 vials packed in a clear, plastic, flip top container with a package insert and lot number stickers included.

DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.